BioPlus Specialty Pharmacy: The 2026 Carelon Ownership Guide

Introduction

In 2026, people searching for “BioPlus Specialty Pharmacy” are rarely looking for a phone number alone. Patients, caregivers, and referring providers usually want answers to bigger questions: Is this pharmacy legitimate? Who owns it now? Is it the right fit for a particular prescription? Those questions became more pressing after Elevance Health, through its Carelon health services division, acquired BioPlus to enhance its specialty pharmacy services and reshaped how it operates.

This guide goes beyond BioPlus’s own brand messaging, such as “Fast. Easy. Done.” and the “Power of 2.” It explains what structurally changed under Carelon ownership, what BioPlus’s accreditations actually cover, and where its business model ends.

It also clarifies a distinction that confuses many patients: the difference between specialty pharmacy dispensing (what BioPlus does) and PCAB-accredited compounding (what pharmacies such as Nationwide Compounding Rx® do). These models complement each other; they are not competitors.

What Is BioPlus Specialty Pharmacy? A Quick Background

BioPlus Specialty Pharmacy was founded in 1989 by Stephen Vogt, Pharm.D., and is headquartered at 376 Northlake Blvd. in Altamonte Springs, Florida.

For most of its history, BioPlus was known as one of the largest independent, pharmacist-owned, URAC accredited specialty infusion pharmacies in the United States, providing high-touch services for patients with chronic diseases. Industry coverage regularly described it as a high-touch, URAC-accredited national specialty infusion pharmacy serving patients with chronic diseases.

Its core mission has remained largely consistent: connecting payors and providers of specialty pharmaceuticals so that patients with complex medical conditions can access the medication therapies they need. That positioning as a bridge between insurers, physicians, and high-cost therapies made BioPlus an attractive acquisition target.

The Carelon Acquisition Timeline: What Actually Changed

BioPlus’s transformation happened in a clear sequence:

• November 2022: Elevance Health (formerly Anthem) announced its agreement to acquire BioPlus.
• February 15, 2023: Elevance completed the acquisition.
• Post-close: BioPlus began operating under CarelonRx, Elevance’s pharmacy benefit manager (PBM). Elevance’s FY2025 Form 10-K confirms this, describing BioPlus as operating “as part of CarelonRx” to connect payors and providers of specialty pharmaceuticals.
• 2024: After CarelonRx acquired Kroger’s specialty pharmacy business, Kroger Specialty Pharmacy was folded into BioPlus, significantly expanding its patient base and operational footprint.

The practical shift is substantial. BioPlus went from an independent, pharmacist-owned company to a PBM-integrated dispensing arm inside one of the largest insurer ecosystems in the country. Payer pages, such as Anthem’s state Medicaid pharmacy pages, now describe BioPlus as “a Carelon company” and an in-network specialty pharmacy option for members.

This move fits a broader pattern. Healthcare trade press has described Elevance’s “specialty care acquisition spree,” in which the company acquired several specialty pharmacy and care-based businesses to build up Carelon’s capacity. BioPlus became one piece of a larger strategy in which the insurer, the PBM, and the dispensing pharmacy all sit under the same corporate roof.

BioPlus’s Accreditation Stack: What VIPPS/URAC/ACHC/CHAP Actually Cover

BioPlus holds a broad set of credentials, and each one signals something specific:

• VIPPS (NABP): The Verified-Accredited Wholesale and Internet Pharmacy credential from the National Association of Boards of Pharmacy confirms that a pharmacy is fully licensed and compliant with applicable state board of pharmacy statutes. It is a trust and safety credential that verifies legitimate operations. It is not a compounding credential.
• URAC: Validates specialty pharmacy operational standards, including patient management, care coordination, and quality processes for handling complex therapies.
• ACHC (Accreditation Commission for Health Care): Typically tied to home infusion and home health service quality.
• CHAP (Community Health Accreditation Program): Focuses on clinical care delivery standards in community and home-based settings.

BioPlus is also licensed in all 50 states plus Puerto Rico, giving it a true national dispensing footprint.

There is one important point for patients to understand. None of these four credentials is equivalent to PCAB accreditation. The Pharmacy Compounding Accreditation Board (PCAB) is the recognized benchmark built specifically for compounding pharmacies. It is structured around USP <795> (non-sterile compounding), USP <797> (sterile compounding), and USP <800> (hazardous drug handling). BioPlus’s credentials confirm that it is a well-run specialty dispensing operation. They say nothing about compounding, because compounding is not what BioPlus does.

What BioPlus Does Well: Core Services Within Its Model

Within its specialty pharmacy model, BioPlus offers a broad and clinically meaningful range of services:

• Specialty pharmacy support for cancer, multiple sclerosis, hepatitis C, autoimmune diseases, rheumatology, and other complex chronic conditions.
• Concierge-class infusion services through BioPlus Infusion, backed by more than 37 years of specialty pharmacy experience and by Carelon’s resources. Drug Channels Institute has ranked Carelon among the top 10 U.S. specialty pharmacies.
• The 2-Hour Patient Acceptance Guarantee, a BioPlus innovation that commits to notifying physician offices within two hours whether a referred patient has been accepted for treatment. For practices managing time-sensitive therapies, that speed matters.
• 340B program participation, including contract pharmacy services, independent audits for contract pharmacies, covered entities, and hospitals, and 340B compliance consulting.

This infrastructure matters because of how specialty drugs shape the healthcare system. Specialty medications make up only about 4 to 5% of prescriptions written in the U.S., yet they account for more than half of total drug spending, with some estimates approaching 60% in 2026. U.S. specialty drug spending grew from roughly $92 billion in 2023 to about $129 billion in 2024, and some projections put the broader U.S. specialty pharmacy market near $965.5 billion by 2030. Biologics and injectables at that cost and complexity require dedicated handling, cold-chain logistics, prior-authorization expertise, and patient monitoring. That is the gap BioPlus was built to fill.

The Structural Limits: What BioPlus Cannot Offer

BioPlus is a PBM-owned dispensing pharmacy, not a PCAB-accredited compounding lab. This is a structural limitation, not a judgment about quality.

Specialty pharmacies like BioPlus dispense pre-manufactured, FDA-approved biologics and injectables exactly as the manufacturer produced them. They do not change the strength, dosage form, or formulation. That rules out several things patients sometimes need:

• Custom dosage forms, such as converting a tablet into a liquid, troche, or suppository for a patient who cannot swallow pills.
• Allergen-free reformulations, including versions without dyes, fillers, or preservatives for patients with sensitivities.
• Flavor or strength personalization, such as pediatric-friendly flavors or non-standard doses calibrated to a patient’s weight or lab results.

Patients who need a discontinued medication strength, non-standard dosing, or an ingredient-free formulation fall outside BioPlus’s operational scope by design. No accreditation, however rigorous, changes that.

This gap is not a BioPlus failure. Compounding is simply outside the specialty pharmacy business model.

The Real-World Patient Experience: What Reviews Reveal

Third-party review platforms show a mixed-to-poor public reputation:

• Trustpilot: BioPlus holds a 1.8/5 TrustScore from 30 reviews. Complaints from 2025 and 2026 focus on delayed shipments, missed refills, billing problems, and slow call-center responses.
• Better Business Bureau: BioPlus Specialty Pharmacy Services, LLC is not a BBB-accredited business. Its profile cites failure to respond to multiple complaints and unresolved disputes during 2024 through 2026.
• Employee reviews: On Glassdoor and Indeed, BioPlus is rated roughly 2.5 to 2.8 out of 5. Recurring themes include micromanagement, heavy metrics pressure, and workplace culture concerns. Internal strain of this kind often shows up in patient-facing service.

A structural explanation is more useful than blame. Several factors likely contribute to these pain points:

1. High patient volume across a 50-state footprint, now inside a very large insurer ecosystem.
2. Prior-authorization bottlenecks, which are common to high-cost specialty therapies and often delay shipments regardless of pharmacy effort.
3. Integration complexity from absorbing Kroger Specialty Pharmacy’s patients, systems, and staff in 2024.

None of this makes BioPlus illegitimate. It does mean that patients should expect the operating realities of a large PBM-owned system and should advocate proactively for refills and authorizations.

Specialty Pharmacy vs. Compounding Pharmacy: Choosing the Right Fit

The core industry distinction is simple:

• Specialty pharmacies dispense pre-manufactured, FDA-approved biologics and injectables for chronic disease.
• Compounding pharmacies create custom, patient-specific formulations that are not available commercially.

A basic decision framework helps patients and providers sort their needs:

Prescription Need	Best-Fit Pharmacy Model
Chronic biologic or injectable therapy (MS, cancer, autoimmune, hepatitis C)	Specialty pharmacy (e.g., BioPlus)
Infusion services for complex chronic conditions	Specialty pharmacy (e.g., BioPlus Infusion)
Customized dosing or non-standard strengths	Compounding pharmacy
Discontinued or commercially unavailable medications	Compounding pharmacy
Allergen-free, dye-free, or flavored formulations	Compounding pharmacy

These models serve entirely different prescription needs. Some patients legitimately need both at once, for example a biologic from a specialty pharmacy alongside a compounded topical or pediatric-flavored medication from a compounding pharmacy.

Nationwide Compounding Rx: The Complementary, Non-PBM-Controlled Alternative

Nationwide Compounding Rx® is a PCAB-accredited, USP 800-compliant compounding pharmacy based in Scottsdale, Arizona. Unlike BioPlus, which sits within the CarelonRx PBM, it operates outside a PBM or insurer ownership structure.

It provides capabilities that BioPlus structurally cannot:

• Custom dosage forms: capsules, liquids, topicals (creams, gels, ointments), troches and lozenges, oral and sublingual tablets, suppositories, and pediatric-specific forms such as flavored liquids, popsicles, and suckers.
• Allergen-free formulations made without dyes, fillers, preservatives, and allergens.
• Flavor customization, including cherry, peppermint, raspberry, strawberry, tutti frutti, marshmallow, orange, bubblegum, and piña colada, plus animal-friendly options. These are especially helpful for children and patients who struggle with taste or swallowing.
• Recreation of discontinued or unavailable strengths when a prescriber determines they are needed.

Its specialty areas include:

• Bioidentical Hormone Replacement Therapy (BHRT), with formulas that can be adjusted at each refill based on updated lab results.
• Pain management topicals that localize treatment and reduce systemic side effects, including addiction risk.
• Dermatology compounds for acne, rosacea, eczema, psoriasis, atopic dermatitis, scarring, stretch marks, dark spots, and aging.
• Pediatric dosing tailored by age and weight, from newborns through teens.
• Sports medicine formulations that support recovery and reduce inflammation.
• GLP-1 and peptide support.

Operationally, Nationwide Compounding Rx offers a 1 to 2 business day turnaround, same-day pickup for some medications, nationwide shipping tiered by state licensing (fully licensed states, non-sterile only states, and pending or unlicensed states), and independent third-party testing. Its chemicals come from FDA-inspected and cleared vendors, and its team brings more than 40 years of combined experience.

Its provider model is built around a collaborative framework: Connect, Collaborate, Create, Care. That relationship-driven approach contrasts with the high-volume, metrics-driven environment described in BioPlus reviews.

Nationwide Compounding Rx is not a replacement for BioPlus’s chronic disease infusion services. It is the logical complement for patients whose prescriber determines that a standard commercial medication will not work as-is.

Conclusion

BioPlus Specialty Pharmacy has been under Carelon and Elevance Health ownership since February 2023 and expanded further with the 2024 absorption of Kroger Specialty Pharmacy. It remains a credible specialty dispensing pharmacy with VIPPS, URAC, ACHC, and CHAP accreditation, national licensure, and real strengths in complex chronic disease therapy and infusion services.

Its PBM-owned structure also sets firm limits. BioPlus does not offer custom dosage forms, allergen-free reformulations, or flavor and strength personalization, and those limits exist regardless of the service fluctuations reflected in online reviews.

The key takeaway for patients, caregivers, and providers is to match the pharmacy model to the prescription need. A standard specialty biologic belongs with a specialty pharmacy. An individualized compound belongs with a PCAB-accredited compounding pharmacy. That match matters more than brand loyalty or convenience.

Need a Personalized Formulation BioPlus Cannot Provide?

Patients whose prescriber has identified a need for custom dosing, allergen-free formulations, or flavor and strength adjustments can contact Nationwide Compounding Rx® directly.

• Phone: (480) 499-8379
• Hours: Monday through Friday, 7:00 AM to 3:30 PM
• Address: 14000 N. Hayden Rd., Suite 104, Scottsdale, AZ 85260 (east side of the building, facing Hayden)

Secure Provider and Patient Portals at nationwidecompounding.com support prescription submission, order tracking, refill management, and secure communication with the pharmacy team.

Healthcare providers can start the Connect, Collaborate, Create, Care partnership process for patients who need individualized compounding, either alongside standard specialty fulfillment or in place of it.